Neuland Labs Executes ₹40 Cr Corporate Guarantee for Gland Pharma

Neuland Laboratories Ltd announced the execution of a corporate guarantee of ₹40 crores in favor of Gland Pharma Limited. This guarantee is in connection with a Loan Licence Agreement to establish dedicated manufacturing capacity and incur capital expenditure for the manufacture of certain products. The company also approved its unaudited financial results for the quarter ended June 30, 2026, and a capacity expansion at its Unit 1 facility. The guarantee represents a contingent liability with no immediate impact on the company's financials. The capacity expansion involves an investment of ₹39.8 crores and is expected to be completed in 6-7 months.